Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Multiple sclerosis-associated retrovirus in early multiple sclerosis: a six-year follow-up of a Sardinian cohort.

Sotgiu S, Arru G, Mameli G, Serra C, Pugliatti M, Rosati G, Dolei A.

Mult Scler. 2006 Dec;12(6):698-703.

PMID:
17262996
2.

Multiple sclerosis-associated retrovirus and optic neuritis.

Sotgiu S, Arru G, Söderström M, Mameli G, Serra C, Dolei A.

Mult Scler. 2006 Jun;12(3):357-9.

PMID:
16764351
3.

Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus/HERV-W endogenous retrovirus, but not Human herpesvirus 6.

Mameli G, Astone V, Arru G, Marconi S, Lovato L, Serra C, Sotgiu S, Bonetti B, Dolei A.

J Gen Virol. 2007 Jan;88(Pt 1):264-74.

PMID:
17170460
4.

The DNA copy number of human endogenous retrovirus-W (MSRV-type) is increased in multiple sclerosis patients and is influenced by gender and disease severity.

Garcia-Montojo M, Dominguez-Mozo M, Arias-Leal A, Garcia-Martinez Á, De las Heras V, Casanova I, Faucard R, Gehin N, Madeira A, Arroyo R, Curtin F, Alvarez-Lafuente R, Perron H.

PLoS One. 2013;8(1):e53623. doi: 10.1371/journal.pone.0053623. Epub 2013 Jan 7.

5.

Multiple sclerosis-associated retrovirus, Epstein-Barr virus, and vitamin D status in patients with relapsing remitting multiple sclerosis.

Mostafa A, Jalilvand S, Shoja Z, Nejati A, Shahmahmoodi S, Sahraian MA, Marashi SM.

J Med Virol. 2017 Jul;89(7):1309-1313. doi: 10.1002/jmv.24774. Epub 2017 Mar 8.

PMID:
28165135
6.

Multiple sclerosis-associated virus-related pol sequences found both in multiple sclerosis and healthy donors are more frequently expressed in multiple sclerosis patients.

Nowak J, Januszkiewicz D, Pernak M, Liweń I, Zawada M, Rembowska J, Nowicka K, Lewandowski K, Hertmanowska H, Wender M.

J Neurovirol. 2003 Feb;9(1):112-7.

PMID:
12587074
7.

Natalizumab inhibits the expression of human endogenous retroviruses of the W family in multiple sclerosis patients: a longitudinal cohort study.

Arru G, Leoni S, Pugliatti M, Mei A, Serra C, Delogu LG, Manetti R, Dolei A, Sotgiu S, Mameli G.

Mult Scler. 2014 Feb;20(2):174-82. doi: 10.1177/1352458513494957. Epub 2013 Jul 22.

PMID:
23877972
8.

Treatment against human endogenous retrovirus: a possible personalized medicine approach for multiple sclerosis.

Curtin F, Perron H, Faucard R, Porchet H, Lang AB.

Mol Diagn Ther. 2015 Oct;19(5):255-65. doi: 10.1007/s40291-015-0166-z.

PMID:
26376649
9.

Correlation between disease severity and in vitro cytokine production mediated by MSRV (multiple sclerosis associated retroviral element) envelope protein in patients with multiple sclerosis.

Rolland A, Jouvin-Marche E, Saresella M, Ferrante P, Cavaretta R, Créange A, Marche P, Perron H.

J Neuroimmunol. 2005 Mar;160(1-2):195-203. Epub 2004 Dec 8.

PMID:
15710473
10.

Analysis of transcribed human endogenous retrovirus W env loci clarifies the origin of multiple sclerosis-associated retrovirus env sequences.

Laufer G, Mayer J, Mueller BF, Mueller-Lantzsch N, Ruprecht K.

Retrovirology. 2009 Apr 15;6:37. doi: 10.1186/1742-4690-6-37.

11.

MSRV pol sequence copy number as a potential marker of multiple sclerosis.

Zawada M, Liwień I, Pernak M, Januszkiewicz-Lewandowska D, Nowicka-Kujawska K, Rembowska J, Lewandowski K, Hertmanowska H, Wender M, Nowak J.

Pol J Pharmacol. 2003 Sep-Oct;55(5):869-75.

12.

HERV-W polymorphism in chromosome X is associated with multiple sclerosis risk and with differential expression of MSRV.

García-Montojo M, de la Hera B, Varadé J, de la Encarnación A, Camacho I, Domínguez-Mozo M, Árias-Leal A, García-Martínez A, Casanova I, Izquierdo G, Lucas M, Fedetz M, Alcina A, Arroyo R, Matesanz F, Urcelay E, Alvarez-Lafuente R.

Retrovirology. 2014 Jan 9;11:2. doi: 10.1186/1742-4690-11-2.

13.

Lack of immune responses against multiple sclerosis-associated retrovirus/human endogenous retrovirus W in patients with multiple sclerosis.

Ruprecht K, Gronen F, Sauter M, Best B, Rieckmann P, Mueller-Lantzsch N.

J Neurovirol. 2008 Apr;14(2):143-51. doi: 10.1080/13550280801958922.

PMID:
18444086
14.

Inhibition of multiple-sclerosis-associated retrovirus as biomarker of interferon therapy.

Mameli G, Serra C, Astone V, Castellazzi M, Poddighe L, Fainardi E, Neri W, Granieri E, Dolei A.

J Neurovirol. 2008 Jan;14(1):73-7. doi: 10.1080/13550280701801107.

PMID:
18300077
15.

The aliens inside human DNA: HERV-W/MSRV/syncytin-1 endogenous retroviruses and neurodegeneration.

Dolei A, Uleri E, Ibba G, Caocci M, Piu C, Serra C.

J Infect Dev Ctries. 2015 Jul 4;9(6):577-87. doi: 10.3855/jidc.6916. Review.

16.

Human endogenous retrovirus W in brain lesions: Rationale for targeted therapy in multiple sclerosis.

van Horssen J, van der Pol S, Nijland P, Amor S, Perron H.

Mult Scler Relat Disord. 2016 Jul;8:11-8. doi: 10.1016/j.msard.2016.04.006. Epub 2016 Apr 22.

17.

Multiple Sclerosis and HERV-W/MSRV: A Multicentric Study.

Arru G, Mameli G, Astone V, Serra C, Huang YM, Link H, Fainardi E, Castellazzi M, Granieri E, Fernandez M, Villoslada P, Fois ML, Sanna A, Rosati G, Dolei A, Sotgiu S.

Int J Biomed Sci. 2007 Dec;3(4):292-7.

18.

Novel reliable real-time PCR for differential detection of MSRVenv and syncytin-1 in RNA and DNA from patients with multiple sclerosis.

Mameli G, Poddighe L, Astone V, Delogu G, Arru G, Sotgiu S, Serra C, Dolei A.

J Virol Methods. 2009 Oct;161(1):98-106. doi: 10.1016/j.jviromet.2009.05.024. Epub 2009 Jun 6.

PMID:
19505508
19.

Multiple sclerosis-associated retroviral agent (MSRV)-stimulated cytokine production in patients with relapsing-remitting multiple sclerosis.

Saresella M, Rolland A, Marventano I, Cavarretta R, Caputo D, Marche P, Perron H, Clerici M.

Mult Scler. 2009 Apr;15(4):443-7. doi: 10.1177/1352458508100840. Epub 2009 Feb 27.

PMID:
19251836
20.

A Novel, Highly Selective RT-QPCR Method for Quantification of MSRV Using PNA Clamping Syncytin-1 (ERVWE1).

Machnik G, Skudrzyk E, Bułdak Ł, Łabuzek K, Ruczyński J, Alenowicz M, Rekowski P, Nowak PJ, Okopień B.

Mol Biotechnol. 2015 Sep;57(9):801-13. doi: 10.1007/s12033-015-9873-2.

Supplemental Content

Support Center